Cipla COO On Joining The Revolution In Manufacturing
Executive Summary
Cipla’s global COO Dr R Ananthanarayanan tells Scrip how the company is rethinking and refining its manufacturing operations in the backdrop of intense competition and evolving customer and regulatory requirements. Digitization and advanced analytics are part of the proposed manufacturing innovation plans.
You may also be interested in...
India CEOs On Automated Plants, New Modalities, Tackling 'The Great Talent Reshuffle'
The top leadership of Cipla, Dr Reddy’s Laboratories, Zydus Cadila, Sun Pharmaceutical Industries and Lupin discuss automation roadmaps, strategies for a play in new modalities and talent acquisition and retention amid the global "great resignation."
'Touchless Plants' To Virtually Trained Workforces - Indian Cos Share Digitalization Tips
Despite AI and digital analytics playing an increasing role in pharma, the industry lags others globally, a recent event heard. Meanwhile, top Indian players including Sun Pharma, Cipla and others shared what is driving their initiatives, ranging from a 'touchless factory' to virtual training and lessons learned along the way.
Cipla's COO Steps Down
Cipla’s global chief operating officer is leaving the company to pursue new interests, amid a spate of top-level exits that have marked the pharma sector in India in 2019.